Document Detail


A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer.
MedLine Citation:
PMID:  2670647     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy and safety of famotidine and ranitidine in the treatment of active duodenal ulcer were compared in a multicenter, randomized double-blind study. The study was carried out in 5 centers which included a total of 143 patients with endoscopically documented active duodenal ulcer. The patients received either famotidine (1 tablet of 40 mg at night) or ranitidine (2 tablets of 150 mg at night). Endoscopic examinations were performed at 4 and 6 weeks of active treatment. Day and nocturnal pain were also monitored and the laboratory and clinical profiles evaluated. One hundred and thirty-three patients fulfilled the evaluation criteria (66 patients in the famotidine group and 67 in the ranitidine group). Healing rates at weeks 4 or 6 of treatment showed no significant differences between the famotidine and the ranitidine groups. The healing rates were 79% at week 4 and 96% at week 6 in the famotidine group, and 77% at week 4 and 95% at week 6 in the ranitidine group. Similar results were observed in both treatment groups with regard to pain resolution, decrease in antacid intake and safety profile.
Authors:
R Alcalá-Santaella; J Guardia; J Pajares; J Piqué; L Pita; E Alvárez; P Castellanos; L Guarner; J Ortiz; R Pesquera
Related Documents :
1882897 - Reflux esophagitis therapy: sucralfate versus ranitidine in a double blind multicenter ...
3299677 - Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years.
2646087 - Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinfla...
18184117 - A randomized, comparative trial of a potassium-competitive acid blocker (azd0865) and e...
2276217 - Investigation and outcome of 121 infants and children requiring nissen fundoplication f...
19195987 - Novel hyaluronate-atelocollagen/beta-tcp-hydroxyapatite biphasic scaffold for the repai...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Duplicate Publication; Journal Article; Multicenter Study; Randomized Controlled Trial    
Journal Detail:
Title:  Digestion     Volume:  42     ISSN:  0012-2823     ISO Abbreviation:  Digestion     Publication Date:  1989  
Date Detail:
Created Date:  1989-09-29     Completed Date:  1989-09-29     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0150472     Medline TA:  Digestion     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  79-85     Citation Subset:  IM    
Affiliation:
Hospital Gregorio Marañón, Madrid, España.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anti-Ulcer Agents / administration & dosage*,  therapeutic use
Double-Blind Method
Drug Administration Schedule
Duodenal Ulcer / drug therapy*
Famotidine
Female
Humans
Male
Multicenter Studies as Topic
Random Allocation
Ranitidine / administration & dosage*,  therapeutic use
Thiazoles / administration & dosage*,  therapeutic use
Time Factors
Wound Healing
Chemical
Reg. No./Substance:
0/Anti-Ulcer Agents; 0/Thiazoles; 66357-35-5/Ranitidine; 76824-35-6/Famotidine
Comments/Corrections
Comment In:
Digestion. 1989;44(4):237   [PMID:  2637217 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac metabolic and hemodynamic effects of insulin in patients with coronary artery disease.
Next Document:  Pulmonary permeability in coeliac disease and inflammatory bowel disease.